{"columns":["p"],"data":[{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2eb64e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502192","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2eb64e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2eb23e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502191","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2eb23e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ead48-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502190","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ead48-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea924-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502189","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea924-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea532-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502188","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea532-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea140-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502187","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2ea140-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9d44-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502186","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9d44-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9952-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502185","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9952-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9560-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502184","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e9560-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e915a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502183","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e915a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e8d5e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502182","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e8d5e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e88fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502181","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e88fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e84f8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502180","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e84f8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e8070-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502179","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e8070-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e7c7e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502178","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e7c7e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e788c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502177","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e788c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e749a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502176","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e749a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e70a8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502175","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e70a8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e6cb6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502174","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e6cb6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e68c4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502173","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e68c4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e64d2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502172","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e64d2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e6068-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502171","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e6068-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e5c80-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502170","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e5c80-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e588e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502169","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e588e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e549c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"502168","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e549c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e50aa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502167","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e50aa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e4cb8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502166","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e4cb8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e48c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502165","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e48c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e44d4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502164","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e44d4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e40d8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502163","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e40d8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e3cbe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502162","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e3cbe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e384a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502161","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e384a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e3412-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"502160","type":"IS_ASSOCIATED_WITH","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":6.14,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"bf2e3412-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","confidence_score":1,"source":"CTD","category":"curated","uuid":"e8556398-ef71-11e5-ae83-005056be9332","source_reference":["PMID:25326323"],"tool":"structured_pipeline","timestamp":1458570818},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"2851677","type":"IS_MARKER_FOR","startNode":"248291","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","confidence_score":1,"source":"CTD","category":"curated","uuid":"e8556398-ef71-11e5-ae83-005056be9332","source_reference":["PMID:25326323"],"tool":"structured_pipeline","timestamp":1458570818}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0754f21c-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:15929893"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"serve","document_section":"sentence","confidence_score":1,"sentence_number":"S30","sentence_text":"If so, then <entity uuid=\"02ffc416-d110-11e5-94a7-005056be9332\" type=\"Chemical\">ATR</entity> exposures may also serve as a risk factor for neurodegenerative diseases and/or dysfunctions associated with these systems, which include <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity>, schizophrenia, and attention deficit disorder, among others (Crossman 2000; Epstein et al. 1999; Viggiano et al. 2003).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"248291","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":215.68,"topical":0,"inorganic_flag":-1,"alogp":2.54,"clinical_flag":0,"freebase_mwt":215.68,"source":"Stratified Medical Dictionary","uuid":"02ffc416-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"QJA9M5H4IM","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":4,"num_ro5_violations":0,"cas_rn":"1912-24-9","chembl_id":"CHEMBL15063","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)","full_molformula":"C8H14ClN5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CCNc1nc(Cl)nc(NC(C)C)n1","standard_inchi_key":"MXWJVTOOROXGIU-UHFFFAOYSA-N","hydrogen_bond_acceptors":5,"pref_name":"Atrazine","parenteral":0,"availability_type":-1,"polar_surface_area":62.73,"aromatic_rings":1,"name":"Atrazine","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"35229724","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"248291","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0754f21c-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:15929893"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"serve","document_section":"sentence","confidence_score":1,"sentence_number":"S30","sentence_text":"If so, then <entity uuid=\"02ffc416-d110-11e5-94a7-005056be9332\" type=\"Chemical\">ATR</entity> exposures may also serve as a risk factor for neurodegenerative diseases and/or dysfunctions associated with these systems, which include <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity>, schizophrenia, and attention deficit disorder, among others (Crossman 2000; Epstein et al. 1999; Viggiano et al. 2003).","category":"extracted","timestamp":1463495465}},{"id":"69968001","type":"INTERACTS_WITH","startNode":"248291","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Atrazine results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6ba9249c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22378314"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf06212-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"958124","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69967995","type":"INTERACTS_WITH","startNode":"958124","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"201769","type":"IS_ASSOCIATED_WITH","startNode":"958124","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf06212-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05e16-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"958124","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69967995","type":"INTERACTS_WITH","startNode":"958124","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"201768","type":"IS_ASSOCIATED_WITH","startNode":"958124","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05e16-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05a24-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"958124","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69967995","type":"INTERACTS_WITH","startNode":"958124","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"201767","type":"IS_ASSOCIATED_WITH","startNode":"958124","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05a24-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05632-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"958124","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69967995","type":"INTERACTS_WITH","startNode":"958124","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"201766","type":"IS_ASSOCIATED_WITH","startNode":"958124","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf05632-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf051e6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"958124","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":168.11,"topical":0,"inorganic_flag":-1,"alogp":1.62,"clinical_flag":0,"freebase_mwt":168.11,"source":"Stratified Medical Dictionary","uuid":"801ffb86-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"DK8B627BU0","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"99-65-0","chembl_id":"CHEMBL114070","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H","full_molformula":"C6H4N2O4","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)c1cccc(c1)[N+](=O)[O-]","standard_inchi_key":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Dinitrophenylene","parenteral":0,"availability_type":-1,"polar_surface_area":91.63,"aromatic_rings":1,"name":"Dinitrophenylene","max_phase":0,"therapeutic_flag":0,"oral":0}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}}],"relationships":[{"id":"69967995","type":"INTERACTS_WITH","startNode":"958124","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"3-dinitrobenzene results in decreased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"68c8d286-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21983209"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"201765","type":"IS_ASSOCIATED_WITH","startNode":"958124","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.16,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"abf051e6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5994e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662357","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5994e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5950c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662356","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5950c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5911a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662355","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5911a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58d50-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662354","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58d50-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58986-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662353","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58986-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58580-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662352","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e58580-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e581b6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662351","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e581b6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57dec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662350","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57dec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57a2c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662349","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57a2c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57662-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662348","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e57662-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5728e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662347","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5728e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e56d7a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662346","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e56d7a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5699c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662345","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5699c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5651e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662344","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5651e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5614a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662343","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5614a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e55cea-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662342","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e55cea-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e557f4-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662341","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e557f4-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e553ee-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662340","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e553ee-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e54fa2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662339","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e54fa2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e54aa2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662338","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e54aa2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5467e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662337","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5467e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e542b4-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662336","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e542b4-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e53e4a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662335","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e53e4a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e53a80-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662334","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e53a80-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e536ac-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662333","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e536ac-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e532ec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662332","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e532ec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52f22-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662331","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52f22-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52afe-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662330","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52afe-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52694-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662329","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52694-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52284-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"2662328","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e52284-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e51e38-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662327","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e51e38-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e519e2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662326","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e519e2-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e515f0-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662325","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e515f0-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e51230-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662324","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e51230-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e50e5c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662323","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e50e5c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e50970-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662322","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e50970-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5059c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2662321","type":"IS_ASSOCIATED_WITH","startNode":"1474131","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":7.39,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"51e5059c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:7"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"0d44a24e-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26364587"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"utilize","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>)-differentiated human neuroblastoma SH-SY5Y cells (SH-SY5Y+RA) have been broadly utilized in studies of mechanisms of the pathogenesis underlying 1-Methyl-4-phenyl pyridinium (MPP(+) )-induced <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> models.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"36028927","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"0d44a24e-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26364587"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"utilize","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>)-differentiated human neuroblastoma SH-SY5Y cells (SH-SY5Y+RA) have been broadly utilized in studies of mechanisms of the pathogenesis underlying 1-Methyl-4-phenyl pyridinium (MPP(+) )-induced <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> models.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":11,"source":"Pubmed","posneg":"Pos","uuid":"0d5255f6-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of RA has been defying, and in this sense we have previously developed novel <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35965530","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":11,"source":"Pubmed","posneg":"Pos","uuid":"0d5255f6-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of RA has been defying, and in this sense we have previously developed novel <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"0d525330-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"defy","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> has been defying, and in this sense we have previously developed novel RA-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35965529","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"0d525330-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"defy","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> has been defying, and in this sense we have previously developed novel RA-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"0d524dcc-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"point","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Recently, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> was pointed as a therapeutic option for some neurodegenerative diseases, including <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity> (PD).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35965527","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"0d524dcc-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"point","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Recently, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> was pointed as a therapeutic option for some neurodegenerative diseases, including <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity> (PD).","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0af08670-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22051113"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"expose","document_section":"sentence","confidence_score":1,"sentence_number":"S5","sentence_text":"In the present study, we set out to elucidate the nature of the interaction between tTG and the ER in PD pathogenesis, using <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic-acid</entity> differentiated SH-SY5Y cells exposed to the <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>-mimetic 1-methyl-4-phenylpyridinium (MPP(+)).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35915991","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0af08670-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22051113"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"expose","document_section":"sentence","confidence_score":1,"sentence_number":"S5","sentence_text":"In the present study, we set out to elucidate the nature of the interaction between tTG and the ER in PD pathogenesis, using <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic-acid</entity> differentiated SH-SY5Y cells exposed to the <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>-mimetic 1-methyl-4-phenylpyridinium (MPP(+)).","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"0ba08778-1c3c-11e6-a934-005056be6d3b","source_reference":["PMID:20664956"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"establish","document_section":"sentence","confidence_score":1,"sentence_number":"S9","sentence_text":"These findings suggest that Am80 induces neuronal differentiation to a greater extent than <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">ATRA</entity> and thus may help establishing therapeutic strategies against neuronal degenerative disorders such as <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35802352","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"0ba08778-1c3c-11e6-a934-005056be6d3b","source_reference":["PMID:20664956"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"establish","document_section":"sentence","confidence_score":1,"sentence_number":"S9","sentence_text":"These findings suggest that Am80 induces neuronal differentiation to a greater extent than <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">ATRA</entity> and thus may help establishing therapeutic strategies against neuronal degenerative disorders such as <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"0b13d88c-1c3c-11e6-8905-005056be6d3b","source_reference":["PMID:22330803"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"explore","document_section":"sentence","confidence_score":1,"sentence_number":"S4","sentence_text":"To explore their therapeutic potential in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, we examined whether CB-SCs could be induced to differentiate into dopamine neurons in the presence of all-trans retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">ATRA</entity>).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35388046","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"0b13d88c-1c3c-11e6-8905-005056be6d3b","source_reference":["PMID:22330803"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"explore","document_section":"sentence","confidence_score":1,"sentence_number":"S4","sentence_text":"To explore their therapeutic potential in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, we examined whether CB-SCs could be induced to differentiate into dopamine neurons in the presence of all-trans retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">ATRA</entity>).","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0b13d5f8-1c3c-11e6-8905-005056be6d3b","source_reference":["PMID:22330803"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"explore","document_section":"sentence","confidence_score":1,"sentence_number":"S4","sentence_text":"To explore their therapeutic potential in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, we examined whether CB-SCs could be induced to differentiate into dopamine neurons in the presence of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">all-trans retinoic acid</entity> (ATRA).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35388045","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0b13d5f8-1c3c-11e6-8905-005056be6d3b","source_reference":["PMID:22330803"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"explore","document_section":"sentence","confidence_score":1,"sentence_number":"S4","sentence_text":"To explore their therapeutic potential in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, we examined whether CB-SCs could be induced to differentiate into dopamine neurons in the presence of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">all-trans retinoic acid</entity> (ATRA).","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"090096fc-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25628533"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S549","sentence_text":"More recent evidence suggests that the nuclear receptor (NR) superfamily of transcription factors including Nuclear receptor-related factor1 (Nurr1), PPARs, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> and glucocorticoid receptors show promise as therapeutic targets for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35258207","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"090096fc-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:25628533"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S549","sentence_text":"More recent evidence suggests that the nuclear receptor (NR) superfamily of transcription factors including Nuclear receptor-related factor1 (Nurr1), PPARs, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> and glucocorticoid receptors show promise as therapeutic targets for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"08d920b8-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:24217228"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"express","document_section":"sentence","confidence_score":1,"sentence_number":"S131","sentence_text":"MPP+ can increase autophagic flux in SH-SY5Y cells, a dopaminergic cell line widely used as a cell culture model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> that expresses tyrosine hydroxylase (TH) and DAT receptors upon differentiation with <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> [6,17,18].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35199527","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"08d920b8-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:24217228"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"express","document_section":"sentence","confidence_score":1,"sentence_number":"S131","sentence_text":"MPP+ can increase autophagic flux in SH-SY5Y cells, a dopaminergic cell line widely used as a cell culture model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> that expresses tyrosine hydroxylase (TH) and DAT receptors upon differentiation with <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> [6,17,18].","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840b792-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"seem","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by retinoic acid and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and retinoic acid have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35130721","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840b792-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"seem","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by retinoic acid and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and retinoic acid have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840ae96-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by retinoic acid and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than retinoic acid.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35130719","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840ae96-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by retinoic acid and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than retinoic acid.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0840a590-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and retinoic acid have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than retinoic acid.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35130717","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0840a590-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S161","sentence_text":"Embryonic stem cells treated by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> and transplanted into Parkinsonian rats relieved apomorphine-induced asymmetric motor behavior; the transplanted cells showed tyrosine hydroxylase immunoreactivity and displayed neuronal and glial features.71 Ulusoy et al72 showed that pioglitazone and retinoic acid have some beneficial effects in a rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity> in rats whereby pioglitazone seemed to be more effective than retinoic acid.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840a0f4-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"play","document_section":"sentence","confidence_score":1,"sentence_number":"S159","sentence_text":"The <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> pathway might play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity>, but also provides a platform for possible treatment approaches.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"35130716","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0840a0f4-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25678793"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"play","document_section":"sentence","confidence_score":1,"sentence_number":"S159","sentence_text":"The <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> pathway might play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson’s disease</entity>, but also provides a platform for possible treatment approaches.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"089388d2-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:19154613"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"contribute","document_section":"sentence","confidence_score":1,"sentence_number":"S314","sentence_text":"The authors concluded that <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> signalling defects may contribute to pathologies such as <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson disease</entity> and schizophrenia.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34886243","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"089388d2-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:19154613"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"contribute","document_section":"sentence","confidence_score":1,"sentence_number":"S314","sentence_text":"The authors concluded that <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> signalling defects may contribute to pathologies such as <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson disease</entity> and schizophrenia.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"082ad6de-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:24116087"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"involve","document_section":"sentence","confidence_score":1,"sentence_number":"S15","sentence_text":"Recently, we have proposed a novel mechanism in which aldehyde dehydrogenase 2 (Ahd2)-mediated <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> production is involved in the neuronal development and maintenance of mdDA neurons in the SNc and VTA, providing new insights into subset-specific vulnerability in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> [7], [14].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34878854","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"082ad6de-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:24116087"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"involve","document_section":"sentence","confidence_score":1,"sentence_number":"S15","sentence_text":"Recently, we have proposed a novel mechanism in which aldehyde dehydrogenase 2 (Ahd2)-mediated <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> production is involved in the neuronal development and maintenance of mdDA neurons in the SNc and VTA, providing new insights into subset-specific vulnerability in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> [7], [14].","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0702d928-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:24885905"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"assume","document_section":"sentence","confidence_score":1,"sentence_number":"S25","sentence_text":"For example, a correlation between the over-expression of WT ASYN and the observed cell loss has been shown in SH-SY5Y cells [8], a human neuroblastoma cell line that upon treatment with <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> assumes a neuronal phenotype; SH-SY5Y cells have often been used to model <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> following various toxicological or molecular insults.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34813590","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"0702d928-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:24885905"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"assume","document_section":"sentence","confidence_score":1,"sentence_number":"S25","sentence_text":"For example, a correlation between the over-expression of WT ASYN and the observed cell loss has been shown in SH-SY5Y cells [8], a human neuroblastoma cell line that upon treatment with <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> assumes a neuronal phenotype; SH-SY5Y cells have often been used to model <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> following various toxicological or molecular insults.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"054796f0-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"lead","document_section":"sentence","confidence_score":1,"sentence_number":"S176","sentence_text":"Thus, if prolonged <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> treatment leads to increased DAT activity beyond the basal activity of primary dopaminergic neurons, a shorter duration of RA treatment may be appropriate to induce SH-SY5Y cells for a dopaminergic model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34720825","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"054796f0-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"lead","document_section":"sentence","confidence_score":1,"sentence_number":"S176","sentence_text":"Thus, if prolonged <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> treatment leads to increased DAT activity beyond the basal activity of primary dopaminergic neurons, a shorter duration of RA treatment may be appropriate to induce SH-SY5Y cells for a dopaminergic model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"05478476-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"evaluate","document_section":"sentence","confidence_score":1,"sentence_number":"S24","sentence_text":"The aim of this study is to evaluate possible differences in the expression levels of apoptosis-related mRNAs (p53, Bax, Bcl-2, and caspase-3) activated by MPP+ using real-time quantitative RT-PCR analysis and evaluate the differential expression of a specific dopaminergic marker tyrosine hydroxylase (TH) in undifferentiated and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated SH-SY5Y cells, for the assessment of suitable and accessible dopaminergic cell models for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> research.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34720821","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"05478476-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"evaluate","document_section":"sentence","confidence_score":1,"sentence_number":"S24","sentence_text":"The aim of this study is to evaluate possible differences in the expression levels of apoptosis-related mRNAs (p53, Bax, Bcl-2, and caspase-3) activated by MPP+ using real-time quantitative RT-PCR analysis and evaluate the differential expression of a specific dopaminergic marker tyrosine hydroxylase (TH) in undifferentiated and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated SH-SY5Y cells, for the assessment of suitable and accessible dopaminergic cell models for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> research.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"05477fe4-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"represent","document_section":"sentence","confidence_score":1,"sentence_number":"S17","sentence_text":"In contrast, another study showed that SH-SY5Y cells become significantly more sensitive to 6-OHDA toxicity during the differentiation process as shown by cell mortality assay and GI50 values of 6-OHDA, suggesting that <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated cells represent a more suitable experimental model for studying the pathophysiology of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> [3].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34720820","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"05477fe4-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"represent","document_section":"sentence","confidence_score":1,"sentence_number":"S17","sentence_text":"In contrast, another study showed that SH-SY5Y cells become significantly more sensitive to 6-OHDA toxicity during the differentiation process as shown by cell mortality assay and GI50 values of 6-OHDA, suggesting that <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated cells represent a more suitable experimental model for studying the pathophysiology of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> [3].","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"05477b3e-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"express","document_section":"sentence","confidence_score":1,"sentence_number":"S16","sentence_text":"When exposed to neurotoxins, such as 1-methyl-4-phenyl-pyridinium ion (MPP+) and 6-hydroxydopamine (6-OHDA), <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated cells expressed higher tolerance as shown by the lower rate of the release of lactate dehydrogenase (LDH), cell mortality, and caspase-3 activation, compared to undifferentiated cells, suggesting that undifferentiated cells are more appropriate for studying neurotoxicity or neuroprotection in experimental <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> research [2].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34720819","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"05477b3e-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:26634154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"express","document_section":"sentence","confidence_score":1,"sentence_number":"S16","sentence_text":"When exposed to neurotoxins, such as 1-methyl-4-phenyl-pyridinium ion (MPP+) and 6-hydroxydopamine (6-OHDA), <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA-</entity>differentiated cells expressed higher tolerance as shown by the lower rate of the release of lactate dehydrogenase (LDH), cell mortality, and caspase-3 activation, compared to undifferentiated cells, suggesting that undifferentiated cells are more appropriate for studying neurotoxicity or neuroprotection in experimental <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> research [2].","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"06325cee-1c3c-11e6-8f13-005056be6d3b","source_reference":["PMID:17592014"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"involve","document_section":"sentence","confidence_score":1,"sentence_number":"S11","sentence_text":"Here, we propose a novel mechanism in which <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> is involved in mdDA neuronal development and maintenance, providing new insights into subset-specific vulnerability in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34607496","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"06325cee-1c3c-11e6-8f13-005056be6d3b","source_reference":["PMID:17592014"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"involve","document_section":"sentence","confidence_score":1,"sentence_number":"S11","sentence_text":"Here, we propose a novel mechanism in which <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> is involved in mdDA neuronal development and maintenance, providing new insights into subset-specific vulnerability in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"065cb85e-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:23285066"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"divide","document_section":"sentence","confidence_score":1,"sentence_number":"S226","sentence_text":"For cell therapy, acute <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> rats were divided into three groups: group (a) received the GFP-tagged 1-day RA-induced tNSCs (n = 4); group (b) received GFP-tagged 5-day <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-induced tNSCs (n = 4); and group (c) received PBS solution as control (n = 4).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34492469","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"065cb85e-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:23285066"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"divide","document_section":"sentence","confidence_score":1,"sentence_number":"S226","sentence_text":"For cell therapy, acute <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> rats were divided into three groups: group (a) received the GFP-tagged 1-day RA-induced tNSCs (n = 4); group (b) received GFP-tagged 5-day <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-induced tNSCs (n = 4); and group (c) received PBS solution as control (n = 4).","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"065cb1f6-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:23285066"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"divide","document_section":"sentence","confidence_score":1,"sentence_number":"S226","sentence_text":"For cell therapy, acute <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> rats were divided into three groups: group (a) received the GFP-tagged 1-day <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-induced tNSCs (n = 4); group (b) received GFP-tagged 5-day RA-induced tNSCs (n = 4); and group (c) received PBS solution as control (n = 4).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34492467","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"065cb1f6-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:23285066"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"divide","document_section":"sentence","confidence_score":1,"sentence_number":"S226","sentence_text":"For cell therapy, acute <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> rats were divided into three groups: group (a) received the GFP-tagged 1-day <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-induced tNSCs (n = 4); group (b) received GFP-tagged 5-day RA-induced tNSCs (n = 4); and group (c) received PBS solution as control (n = 4).","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"05a6d23c-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"useful","document_section":"sentence","confidence_score":1,"sentence_number":"S783","sentence_text":"Finally, the sensitivity of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-treated SH-SY5Y to MPP(+) may be very useful in functional screening experiments investigating mitochondrial dysfunction in PD and the potential modifying effect of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> target genes towards the MPP(+) induced mitochondrial stress.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34443616","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"05a6d23c-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"useful","document_section":"sentence","confidence_score":1,"sentence_number":"S783","sentence_text":"Finally, the sensitivity of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-treated SH-SY5Y to MPP(+) may be very useful in functional screening experiments investigating mitochondrial dysfunction in PD and the potential modifying effect of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> target genes towards the MPP(+) induced mitochondrial stress.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"05a6cf9e-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"useful","document_section":"sentence","confidence_score":1,"sentence_number":"S783","sentence_text":"Finally, the sensitivity of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-treated SH-SY5Y to MPP(+) may be very useful in functional screening experiments investigating mitochondrial dysfunction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> and the potential modifying effect of PD target genes towards the MPP(+) induced mitochondrial stress.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34443615","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":7,"source":"Pubmed","posneg":"Pos","uuid":"05a6cf9e-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"useful","document_section":"sentence","confidence_score":1,"sentence_number":"S783","sentence_text":"Finally, the sensitivity of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-treated SH-SY5Y to MPP(+) may be very useful in functional screening experiments investigating mitochondrial dysfunction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> and the potential modifying effect of PD target genes towards the MPP(+) induced mitochondrial stress.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"05a6ccf6-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"model","document_section":"sentence","confidence_score":1,"sentence_number":"S723","sentence_text":"This study thus extensively describes the molecular changes induced by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> treatment in SH-SY5Y cells and demonstrates that MPP(+) can be used to model <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>-associated mitochondrial dysfunction in vitro.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34443614","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"05a6ccf6-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:23724009"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"model","document_section":"sentence","confidence_score":1,"sentence_number":"S723","sentence_text":"This study thus extensively describes the molecular changes induced by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> treatment in SH-SY5Y cells and demonstrates that MPP(+) can be used to model <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>-associated mitochondrial dysfunction in vitro.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"063e0b34-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to retinoic acid receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand all-trans-retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34276267","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"063e0b34-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to retinoic acid receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand all-trans-retinoic acid (<entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"063dfdec-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to retinoic acid receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">all-trans-retinoic acid</entity> (RA), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34276264","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"063dfdec-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to retinoic acid receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">all-trans-retinoic acid</entity> (RA), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"063df162-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand all-trans-retinoic acid (RA), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34276261","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"063df162-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:19519313"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"take","document_section":"sentence","confidence_score":1,"sentence_number":"S8","sentence_text":"This paper deals mainly with AD in relation to <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> receptors (RARs: RARα, β and γ) and their ligands (retinoids), such as the endogenous RAR ligand all-trans-retinoic acid (RA), taking into account knowledge about <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ALS and other neurodegenerative diseases.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"03dc69ee-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"release","document_section":"sentence","confidence_score":1,"sentence_number":"S277","sentence_text":"Herein, we reported for the first time the neuroprotective effect on DA neurons triggered by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> released from NPs on a MPTP mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34245458","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"03dc69ee-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"release","document_section":"sentence","confidence_score":1,"sentence_number":"S277","sentence_text":"Herein, we reported for the first time the neuroprotective effect on DA neurons triggered by <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> released from NPs on a MPTP mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":11,"source":"Pubmed","posneg":"Pos","uuid":"03dc4662-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of RA has been defying, and in this sense we have previously developed novel <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34245450","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":11,"source":"Pubmed","posneg":"Pos","uuid":"03dc4662-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of RA has been defying, and in this sense we have previously developed novel <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"03dc413a-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"defy","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> has been defying, and in this sense we have previously developed novel RA-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"34245449","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"03dc413a-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"defy","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The administration of <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> has been defying, and in this sense we have previously developed novel RA-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}},{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"03dc388e-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"point","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Recently, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> was pointed as a therapeutic option for some neurodegenerative diseases, including <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity> (PD).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34245447","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"03dc388e-1c3c-11e6-b6a6-005056be6d3b","source_reference":["PMID:25798108"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"point","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Recently, <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity> was pointed as a therapeutic option for some neurodegenerative diseases, including <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity> (PD).","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"03fb0840-1c3c-11e6-9548-005056be6d3b","source_reference":["PMID:24275787"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"investigate","document_section":"sentence","confidence_score":1,"sentence_number":"S77","sentence_text":"To further investigate the neuroprotective role in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, it was necessary to differentiate SH-SY5Y neuroblastoma cells toward the DAergic phenotype using <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>/PMA [34,35].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34187959","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":8,"source":"Pubmed","posneg":"Pos","uuid":"03fb0840-1c3c-11e6-9548-005056be6d3b","source_reference":["PMID:24275787"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"investigate","document_section":"sentence","confidence_score":1,"sentence_number":"S77","sentence_text":"To further investigate the neuroprotective role in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, it was necessary to differentiate SH-SY5Y neuroblastoma cells toward the DAergic phenotype using <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">RA</entity>/PMA [34,35].","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"05b7e112-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21600965"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S14","sentence_text":"Our results suggest that pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> have some beneficial effects on rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> in rats.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33945599","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"05b7e112-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21600965"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"have","document_section":"sentence","confidence_score":1,"sentence_number":"S14","sentence_text":"Our results suggest that pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity> have some beneficial effects on rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> in rats.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"05b7dbb8-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21600965"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"investigate","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The aim of the present study was to investigate the effects of pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity>, antioxidant and neuroprotective agents, on rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> in rats.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1474131","labels":["All","Molecule","Compound"],"properties":{"prodrug":0,"full_mwt":300.44,"topical":1,"inorganic_flag":0,"alogp":5.55,"clinical_flag":1,"freebase_mwt":300.44,"source":"Stratified Medical Dictionary","uuid":"dca36d2c-d10f-11e5-94a7-005056be9332","approved_flag":1,"unii":"5688UTC01R","source_version":"DICT_COMPOUND_160211","natural_product":1,"rotable_bonds":5,"indication_class":"Keratolytic","num_ro5_violations":1,"cas_rn":"302-79-4","chembl_id":"CHEMBL38","black_box_warning":1,"timestamp":1457446316,"standard_inchi":"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","usan_year":1970,"full_molformula":"C20H28O2","chirality":2,"hydrogen_bond_donors":1,"usan_stem_definition":"retinol derivatives","canonical_smiles":"C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C","atc_level5":["D10AD01","D10AD51","L01XX14"],"standard_inchi_key":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","hydrogen_bond_acceptors":2,"pref_name":"Tretinoin","parenteral":0,"availability_type":1,"polar_surface_area":37.29,"first_approval":1971,"aromatic_rings":0,"name":"Tretinoin","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Tretinoin"]}}],"relationships":[{"id":"69967996","type":"INTERACTS_WITH","startNode":"1474131","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Tretinoin results in decreased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7da80b72-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21934132"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33945597","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"1474131","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"05b7dbb8-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21600965"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"investigate","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"The aim of the present study was to investigate the effects of pioglitazone and <entity uuid=\"dca36d2c-d10f-11e5-94a7-005056be9332\" type=\"Chemical\">retinoic acid</entity>, antioxidant and neuroprotective agents, on rotenone-induced model of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> in rats.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acbbbc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"893569","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acbbbc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acb7c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"893568","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acb7c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acb3c4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"893567","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acb3c4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acafb4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"893566","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acafb4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acab0e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"893565","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7acab0e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7aca6a4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"893564","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7aca6a4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7aca2c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"893563","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7aca2c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7ac9ef2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"893562","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7ac9ef2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7ac9b1e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"621308","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":268.22,"topical":0,"inorganic_flag":-1,"alogp":3.06,"clinical_flag":0,"freebase_mwt":268.22,"source":"Stratified Medical Dictionary","uuid":"4543d1f0-d110-11e5-94a7-005056be9332","approved_flag":0,"unii":"V7NW98OB34","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":0,"num_ro5_violations":0,"cas_rn":"479-13-0","chembl_id":"CHEMBL30707","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H","full_molformula":"C15H8O5","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1","standard_inchi_key":"ZZIALNLLNHEQPJ-UHFFFAOYSA-N","hydrogen_bond_acceptors":4,"pref_name":"Coumestrol","parenteral":0,"availability_type":-1,"polar_surface_area":79.9,"aromatic_rings":3,"name":"Coumestrol","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"893561","type":"IS_ASSOCIATED_WITH","startNode":"621308","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":2.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d7ac9b1e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:2"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967998","type":"INTERACTS_WITH","startNode":"621308","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Coumestrol results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"70a87a38-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:19167446"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bleomycetin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6f4c1dca-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21040473"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":1440.56,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"freebase_mwt":1440.56,"source":"Stratified Medical Dictionary","uuid":"f0d89672-d11a-11e5-94a7-005056be9332","approved_flag":0,"source_version":"DICT_COMPOUND_160211","natural_product":-1,"chembl_id":"CHEMBL2002141","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C57H89N19O21S2/c1-22-35(73-48(76-46(22)61)27(14-33(60)80)68-15-26(59)47(62)86)52(90)75-37(43(28-16-65-21-69-28)95-56-45(41(84)39(82)31(17-77)94-56)96-55-42(85)44(97-57(63)92)40(83)32(18-78)93-55)53(91)70-24(3)38(81)23(2)49(87)74-36(25(4)79)51(89)67-13-8-34-71-30(20-98-34)54-72-29(19-99-54)50(88)66-12-7-11-64-10-6-5-9-58/h16,19-21,23-27,31-32,36-45,55-56,64,68,77-79,81-85H,5-15,17-18,58-59H2,1-4H3,(H2,60,80)(H2,62,86)(H2,63,92)(H,65,69)(H,66,88)(H,67,89)(H,70,91)(H,74,87)(H,75,90)(H2,61,73,76)","full_molformula":"C57H89N19O21S2","chirality":-1,"canonical_smiles":"CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(=O)N)NCC(N)C(=O)N)C(OC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(OC(=O)N)C3O)c4c[nH]cn4)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCNCCCCN","standard_inchi_key":"QYOAUOAXCQAEMW-UHFFFAOYSA-N","parenteral":0,"availability_type":-1,"name":"CHEMBL2002141","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":3.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8bdf1ac-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1584643","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":1440.56,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"freebase_mwt":1440.56,"source":"Stratified Medical Dictionary","uuid":"f0d89672-d11a-11e5-94a7-005056be9332","approved_flag":0,"source_version":"DICT_COMPOUND_160211","natural_product":-1,"chembl_id":"CHEMBL2002141","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C57H89N19O21S2/c1-22-35(73-48(76-46(22)61)27(14-33(60)80)68-15-26(59)47(62)86)52(90)75-37(43(28-16-65-21-69-28)95-56-45(41(84)39(82)31(17-77)94-56)96-55-42(85)44(97-57(63)92)40(83)32(18-78)93-55)53(91)70-24(3)38(81)23(2)49(87)74-36(25(4)79)51(89)67-13-8-34-71-30(20-98-34)54-72-29(19-99-54)50(88)66-12-7-11-64-10-6-5-9-58/h16,19-21,23-27,31-32,36-45,55-56,64,68,77-79,81-85H,5-15,17-18,58-59H2,1-4H3,(H2,60,80)(H2,62,86)(H2,63,92)(H,65,69)(H,66,88)(H,67,89)(H,70,91)(H,74,87)(H,75,90)(H2,61,73,76)","full_molformula":"C57H89N19O21S2","chirality":-1,"canonical_smiles":"CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(=O)N)NCC(N)C(=O)N)C(OC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(OC(=O)N)C3O)c4c[nH]cn4)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCNCCCCN","standard_inchi_key":"QYOAUOAXCQAEMW-UHFFFAOYSA-N","parenteral":0,"availability_type":-1,"name":"CHEMBL2002141","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"655423","type":"IS_ASSOCIATED_WITH","startNode":"1584643","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8bdf1ac-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968000","type":"INTERACTS_WITH","startNode":"1584643","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bleomycetin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6f4c1dca-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21040473"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bleomycetin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6f4c1dca-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21040473"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":1440.56,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"freebase_mwt":1440.56,"source":"Stratified Medical Dictionary","uuid":"f0d89672-d11a-11e5-94a7-005056be9332","approved_flag":0,"source_version":"DICT_COMPOUND_160211","natural_product":-1,"chembl_id":"CHEMBL2002141","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C57H89N19O21S2/c1-22-35(73-48(76-46(22)61)27(14-33(60)80)68-15-26(59)47(62)86)52(90)75-37(43(28-16-65-21-69-28)95-56-45(41(84)39(82)31(17-77)94-56)96-55-42(85)44(97-57(63)92)40(83)32(18-78)93-55)53(91)70-24(3)38(81)23(2)49(87)74-36(25(4)79)51(89)67-13-8-34-71-30(20-98-34)54-72-29(19-99-54)50(88)66-12-7-11-64-10-6-5-9-58/h16,19-21,23-27,31-32,36-45,55-56,64,68,77-79,81-85H,5-15,17-18,58-59H2,1-4H3,(H2,60,80)(H2,62,86)(H2,63,92)(H,65,69)(H,66,88)(H,67,89)(H,70,91)(H,74,87)(H,75,90)(H2,61,73,76)","full_molformula":"C57H89N19O21S2","chirality":-1,"canonical_smiles":"CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(=O)N)NCC(N)C(=O)N)C(OC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(OC(=O)N)C3O)c4c[nH]cn4)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCNCCCCN","standard_inchi_key":"QYOAUOAXCQAEMW-UHFFFAOYSA-N","parenteral":0,"availability_type":-1,"name":"CHEMBL2002141","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":3.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8bdedb0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"1584643","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":1440.56,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"freebase_mwt":1440.56,"source":"Stratified Medical Dictionary","uuid":"f0d89672-d11a-11e5-94a7-005056be9332","approved_flag":0,"source_version":"DICT_COMPOUND_160211","natural_product":-1,"chembl_id":"CHEMBL2002141","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C57H89N19O21S2/c1-22-35(73-48(76-46(22)61)27(14-33(60)80)68-15-26(59)47(62)86)52(90)75-37(43(28-16-65-21-69-28)95-56-45(41(84)39(82)31(17-77)94-56)96-55-42(85)44(97-57(63)92)40(83)32(18-78)93-55)53(91)70-24(3)38(81)23(2)49(87)74-36(25(4)79)51(89)67-13-8-34-71-30(20-98-34)54-72-29(19-99-54)50(88)66-12-7-11-64-10-6-5-9-58/h16,19-21,23-27,31-32,36-45,55-56,64,68,77-79,81-85H,5-15,17-18,58-59H2,1-4H3,(H2,60,80)(H2,62,86)(H2,63,92)(H,65,69)(H,66,88)(H,67,89)(H,70,91)(H,74,87)(H,75,90)(H2,61,73,76)","full_molformula":"C57H89N19O21S2","chirality":-1,"canonical_smiles":"CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(=O)N)NCC(N)C(=O)N)C(OC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(OC(=O)N)C3O)c4c[nH]cn4)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCNCCCCN","standard_inchi_key":"QYOAUOAXCQAEMW-UHFFFAOYSA-N","parenteral":0,"availability_type":-1,"name":"CHEMBL2002141","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"655422","type":"IS_ASSOCIATED_WITH","startNode":"1584643","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8bdedb0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968000","type":"INTERACTS_WITH","startNode":"1584643","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bleomycetin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6f4c1dca-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:21040473"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8671b5c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649989","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8671b5c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8671710-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649988","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8671710-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86712f6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649987","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86712f6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8670df6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649986","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8670df6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86709fa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649985","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86709fa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86705fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649984","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86705fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8670202-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649983","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8670202-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866fe10-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649982","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866fe10-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866fa14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649981","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866fa14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866f618-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649980","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866f618-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866f21c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649979","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866f21c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866ee20-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649978","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866ee20-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e9c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"649977","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e9c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e5a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649976","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e5a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e1b4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649975","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866e1b4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866ddb8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649974","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866ddb8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d9c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649973","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d9c6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d5ca-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649972","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d5ca-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d1b0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649971","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866d1b0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866cd82-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649970","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866cd82-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c99a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649969","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c99a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c594-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649968","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c594-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c116-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649967","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866c116-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866bc98-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649966","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866bc98-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b8a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649965","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b8a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b4b4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649964","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b4b4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b0ae-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649963","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866b0ae-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866aca8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649962","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866aca8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a834-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"649961","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a834-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a424-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649960","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a424-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a01e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649959","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866a01e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8669ba0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649958","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8669ba0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86697a4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649957","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86697a4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86693a8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649956","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86693a8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668fb6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649955","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668fb6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668b9c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649954","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668b9c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668778-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649953","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8668778-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866837c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649952","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866837c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667f8a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649951","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667f8a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667b8e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649950","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667b8e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667788-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649949","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667788-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667314-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649948","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8667314-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666f18-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649947","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666f18-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666a90-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649946","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666a90-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666694-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"649945","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8666694-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86662a2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649944","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86662a2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665e92-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649943","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665e92-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665a32-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649942","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665a32-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866562c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649941","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866562c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665230-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649940","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8665230-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8664dbc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649939","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8664dbc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86649ca-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649938","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86649ca-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86645ce-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649937","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86645ce-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86641dc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649936","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86641dc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8663dd6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649935","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8663dd6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86639da-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649934","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86639da-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86635de-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649933","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86635de-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8663192-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649932","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8663192-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8662d96-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649931","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8662d96-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8662986-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649930","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c8662986-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86624fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"649929","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c86624fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866210c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"534403","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":228.29,"topical":0,"inorganic_flag":-1,"alogp":3.78,"clinical_flag":0,"freebase_mwt":228.29,"source":"Stratified Medical Dictionary","uuid":"360c614c-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"MLT3645I99","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":2,"num_ro5_violations":0,"cas_rn":"80-05-7","chembl_id":"CHEMBL418971","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3","full_molformula":"C15H16O2","chirality":-1,"hydrogen_bond_donors":2,"canonical_smiles":"CC(C)(c1ccc(O)cc1)c2ccc(O)cc2","standard_inchi_key":"IISBACLAFKSPIT-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Bisphenol A","parenteral":0,"availability_type":-1,"polar_surface_area":40.46,"aromatic_rings":2,"name":"Bisphenol A","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967994","type":"INTERACTS_WITH","startNode":"534403","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"bisphenol A results in increased expression of TMEM230 mRNA","uniprot_id":"Q5BJP5","source":"CTD","category":"curated","uuid":"6f216e2c-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:25181051"],"tax_id":10116,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"649928","type":"IS_ASSOCIATED_WITH","startNode":"534403","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":4.13,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"c866210c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"chembl_21","confidence_score":1,"max_phase":1,"source":"chembl","category":"inferred","uuid":"243cecd8-ef71-11e5-ae83-005056be9332","source_reference":["PMID:24214965"],"tool":"structured_pipeline","timestamp":1458570443},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"9705150","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"chembl_21","confidence_score":1,"max_phase":1,"source":"chembl","category":"inferred","uuid":"243cecd8-ef71-11e5-ae83-005056be9332","source_reference":["PMID:24214965"],"tool":"structured_pipeline","timestamp":1458570443}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1600c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306058","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1600c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a15bf2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306057","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a15bf2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a157d8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306056","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a157d8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1536e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306055","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1536e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14f7c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306054","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14f7c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14b8a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306053","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14b8a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14798-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306052","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a14798-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a143a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306051","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a143a6-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a13faa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306050","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a13faa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a13bae-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306049","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a13bae-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a137bc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306048","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a137bc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a133c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306047","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a133c0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a12f06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306046","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a12f06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a12b14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306045","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a12b14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a126fa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306044","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a126fa-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a122e0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306043","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a122e0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a11eee-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306042","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a11eee-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a11a66-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306041","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a11a66-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1166a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306040","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1166a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1123c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306039","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a1123c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a10e40-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306038","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a10e40-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a10a26-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306037","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a10a26-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a105d0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306036","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a105d0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a101de-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306035","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a101de-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0fde2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306034","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0fde2-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f9f0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306033","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f9f0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f5fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306032","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f5fe-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f202-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306031","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0f202-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ee06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306030","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ee06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ea14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306029","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ea14-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0e618-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306028","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0e618-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0e19a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306027","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0e19a-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0dd9e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306026","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0dd9e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d9ac-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306025","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d9ac-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d5ba-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306024","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d5ba-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d1c8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306023","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0d1c8-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0cdcc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306022","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0cdcc-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c94e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306021","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c94e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c548-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306020","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c548-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c156-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306019","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0c156-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0bd50-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306018","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0bd50-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b8f0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306017","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b8f0-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b4f4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306016","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b4f4-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b102-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306015","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0b102-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ad10-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306014","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0ad10-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a91e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306013","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a91e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a52c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"306012","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a52c-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a144-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"306011","type":"IS_ASSOCIATED_WITH","startNode":"246911","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":3.78,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"b2a0a144-fd64-11e5-b260-005056be9332","source_reference":["OMIM:4"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0d05b02a-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:20308684"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"report","document_section":"sentence","confidence_score":1,"sentence_number":"S6","sentence_text":"Seven studies were identified that met the inclusion criteria, all of which reported associations between nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) and <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, 6 of which reported on aspirin, and 2 of which reported on <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"35765175","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0d05b02a-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:20308684"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"report","document_section":"sentence","confidence_score":1,"sentence_number":"S6","sentence_text":"Seven studies were identified that met the inclusion criteria, all of which reported associations between nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) and <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, 6 of which reported on aspirin, and 2 of which reported on <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>.","category":"extracted","timestamp":1463495465}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"0adda62c-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:2327103"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"administer","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Low dose (500 mg) paracetamol <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">(acetaminophen)</entity> was administered to patients with <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>, motor neurone disease and to age-matched controls.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35717978","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"0adda62c-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:2327103"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"administer","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Low dose (500 mg) paracetamol <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">(acetaminophen)</entity> was administered to patients with <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>, motor neurone disease and to age-matched controls.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0add7d14-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:2327103"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"administer","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Low dose (500 mg) <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> (acetaminophen) was administered to patients with <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>, motor neurone disease and to age-matched controls.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35717976","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"0add7d14-1c3c-11e6-adcf-005056be6d3b","source_reference":["PMID:2327103"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"administer","document_section":"sentence","confidence_score":1,"sentence_number":"S2","sentence_text":"Low dose (500 mg) <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> (acetaminophen) was administered to patients with <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">Parkinson's disease</entity>, motor neurone disease and to age-matched controls.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"0b88a4fa-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:18514411"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"represent","document_section":"sentence","confidence_score":1,"sentence_number":"S7","sentence_text":"Taken together, these studies imply an activity for <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> in the attenuation of DA neuron loss that, following essential corroborative analyses in mammalian systems, may represent a potential benefit for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35665083","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"0b88a4fa-1c3c-11e6-b673-005056be6d3b","source_reference":["PMID:18514411"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"represent","document_section":"sentence","confidence_score":1,"sentence_number":"S7","sentence_text":"Taken together, these studies imply an activity for <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> in the attenuation of DA neuron loss that, following essential corroborative analyses in mammalian systems, may represent a potential benefit for <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":4,"source":"Pubmed","posneg":"Neg","uuid":"091a112c-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21331154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S548","sentence_text":"On the other hand, according to meta-analyses of NSAID studies in PD, ibuprofen shows a slight protection against <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> whereas aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> did not show any protective effects [213, 214].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35204471","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":4,"source":"Pubmed","posneg":"Neg","uuid":"091a112c-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21331154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S548","sentence_text":"On the other hand, according to meta-analyses of NSAID studies in PD, ibuprofen shows a slight protection against <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> whereas aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> did not show any protective effects [213, 214].","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":5,"source":"Pubmed","posneg":"Neg","uuid":"091a0e84-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21331154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S548","sentence_text":"On the other hand, according to meta-analyses of NSAID studies in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ibuprofen shows a slight protection against PD whereas aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> did not show any protective effects [213, 214].","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35204470","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":5,"source":"Pubmed","posneg":"Neg","uuid":"091a0e84-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21331154"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"show","document_section":"sentence","confidence_score":1,"sentence_number":"S548","sentence_text":"On the other hand, according to meta-analyses of NSAID studies in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, ibuprofen shows a slight protection against PD whereas aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> did not show any protective effects [213, 214].","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":4,"source":"Pubmed","posneg":"Neg","uuid":"07a1c29a-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"modify","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding PD diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, which may underlie this finding.31, 51, 52 Aspirin and acetaminophen/<entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> did not modify risk significantly.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35023387","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":4,"source":"Pubmed","posneg":"Neg","uuid":"07a1c29a-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"modify","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding PD diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, which may underlie this finding.31, 51, 52 Aspirin and acetaminophen/<entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> did not modify risk significantly.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":10,"source":"Pubmed","posneg":"Neg","uuid":"07a1bdd6-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"modify","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of PD, which may underlie this finding.31, 51, 52 Aspirin and acetaminophen/<entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> did not modify risk significantly.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35023386","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":10,"source":"Pubmed","posneg":"Neg","uuid":"07a1bdd6-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"modify","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of PD, which may underlie this finding.31, 51, 52 Aspirin and acetaminophen/<entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">paracetamol</entity> did not modify risk significantly.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"07a1b91c-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"underlie","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding PD diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, which may underlie this finding.31, 51, 52 Aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>/paracetamol did not modify risk significantly.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35023385","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":4,"source":"Pubmed","posneg":"Pos","uuid":"07a1b91c-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"underlie","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding PD diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>, which may underlie this finding.31, 51, 52 Aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>/paracetamol did not modify risk significantly.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"07a1b3c2-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"be","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of PD, which may underlie this finding.31, 51, 52 Aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>/paracetamol did not modify risk significantly.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"35023384","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":10,"source":"Pubmed","posneg":"Pos","uuid":"07a1b3c2-1c3c-11e6-88ee-005056be6d3b","source_reference":["PMID:23071076"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"be","document_section":"sentence","confidence_score":1,"sentence_number":"S109","sentence_text":"A similar finding has recently been published in a Cochrane review of NSAIDs preceding <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> diagnosis.50 There is increasing evidence that inflammation may play a role in the pathogenesis of PD, which may underlie this finding.31, 51, 52 Aspirin and <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>/paracetamol did not modify risk significantly.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"03a3b180-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22125548"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"observe","document_section":"sentence","confidence_score":1,"sentence_number":"S427","sentence_text":"A reduction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk was observed with Ibuprofen, but not NSAIDS or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">Acetaminophen</entity>","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"34456848","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"03a3b180-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22125548"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"observe","document_section":"sentence","confidence_score":1,"sentence_number":"S427","sentence_text":"A reduction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk was observed with Ibuprofen, but not NSAIDS or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">Acetaminophen</entity>","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"039d5d3a-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22125548"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"be","document_section":"sentence","confidence_score":1,"sentence_number":"S197","sentence_text":"In humans there was a reduction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk observed in individuals who use Ibuprofen, but no reduction was found in individuals who use NSAIDS or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">Acetaminophen</entity> (Chen et al., 2005; Ton et al., 2006; Driver et al., 2011; Gao et al., 2011).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"34456824","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":9,"source":"Pubmed","posneg":"Pos","uuid":"039d5d3a-1c3c-11e6-87c4-005056be6d3b","source_reference":["PMID:22125548"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"be","document_section":"sentence","confidence_score":1,"sentence_number":"S197","sentence_text":"In humans there was a reduction in <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk observed in individuals who use Ibuprofen, but no reduction was found in individuals who use NSAIDS or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">Acetaminophen</entity> (Chen et al., 2005; Ton et al., 2006; Driver et al., 2011; Gao et al., 2011).","category":"extracted","timestamp":1463495465}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":5,"source":"Pubmed","posneg":"Neg","uuid":"04110e24-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21457177"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"associate","document_section":"sentence","confidence_score":1,"sentence_number":"S13","sentence_text":"In this large observational study with data from the UK primary care, the long-term use of NSAIDs, aspirin, or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> was not associated with a substantially altered risk of developing <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33921199","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":5,"source":"Pubmed","posneg":"Neg","uuid":"04110e24-1c3c-11e6-9cd6-005056be6d3b","source_reference":["PMID:21457177"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"associate","document_section":"sentence","confidence_score":1,"sentence_number":"S13","sentence_text":"In this large observational study with data from the UK primary care, the long-term use of NSAIDs, aspirin, or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> was not associated with a substantially altered risk of developing <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"050407a0-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"suggest","document_section":"sentence","confidence_score":1,"sentence_number":"S12","sentence_text":"The association between use of ibuprofen and lower PD risks, not shared by other NSAIDs or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>, suggests ibuprofen should be further investigated as a potential neuroprotective agent against <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33811418","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"050407a0-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"suggest","document_section":"sentence","confidence_score":1,"sentence_number":"S12","sentence_text":"The association between use of ibuprofen and lower PD risks, not shared by other NSAIDs or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>, suggests ibuprofen should be further investigated as a potential neuroprotective agent against <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity>.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"050404f8-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"share","document_section":"sentence","confidence_score":1,"sentence_number":"S12","sentence_text":"The association between use of ibuprofen and lower <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risks, not shared by other NSAIDs or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>, suggests ibuprofen should be further investigated as a potential neuroprotective agent against PD.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33811417","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":5,"source":"Pubmed","posneg":"Pos","uuid":"050404f8-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"share","document_section":"sentence","confidence_score":1,"sentence_number":"S12","sentence_text":"The association between use of ibuprofen and lower <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risks, not shared by other NSAIDs or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity>, suggests ibuprofen should be further investigated as a potential neuroprotective agent against PD.","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"05040246-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"use","document_section":"sentence","confidence_score":1,"sentence_number":"S10","sentence_text":"In contrast, <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk was not significantly related to use of aspirin (RR = 0.99; 95% CI 0.78-1.26), other NSAIDs (RR = 1.26; 95% CI 0.86-1.84), or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> (RR = 0.86; 95% CI 0.62-1.18).","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"33811416","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":3,"source":"Pubmed","posneg":"Pos","uuid":"05040246-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:21368281"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"use","document_section":"sentence","confidence_score":1,"sentence_number":"S10","sentence_text":"In contrast, <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> risk was not significantly related to use of aspirin (RR = 0.99; 95% CI 0.78-1.26), other NSAIDs (RR = 1.26; 95% CI 0.86-1.84), or <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> (RR = 0.86; 95% CI 0.62-1.18).","category":"extracted","timestamp":1463495465}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"047bc156-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:2739915"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"discharge","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"When we studied acetaminophen <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">(paracetamol)</entity> metabolism, only 29.6% of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> patients excreted greater than 5% of the dose as the sulfate conjugate; the corresponding figure for controls was 83.9%.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"33802823","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"047bc156-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:2739915"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"discharge","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"When we studied acetaminophen <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">(paracetamol)</entity> metabolism, only 29.6% of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> patients excreted greater than 5% of the dose as the sulfate conjugate; the corresponding figure for controls was 83.9%.","category":"extracted","timestamp":1463495465}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]},{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"047bbeae-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:2739915"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"discharge","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"When we studied <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> (paracetamol) metabolism, only 29.6% of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> patients excreted greater than 5% of the dose as the sulfate conjugate; the corresponding figure for controls was 83.9%.","category":"extracted","timestamp":1463495465},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"246911","labels":["All","Molecule","Compound"],"properties":{"prodrug":1,"full_mwt":151.16,"topical":1,"inorganic_flag":0,"alogp":0.71,"clinical_flag":1,"freebase_mwt":151.16,"source":"Stratified Medical Dictionary","uuid":"02bbd9fe-d110-11e5-94a7-005056be9332","approved_flag":1,"unii":"362O9ITL9D","source_version":"DICT_COMPOUND_160211","natural_product":0,"rotable_bonds":1,"indication_class":"Analgesic; Antipyretic","num_ro5_violations":0,"cas_rn":"103-90-2","chembl_id":"CHEMBL112","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)","full_molformula":"C8H9NO2","chirality":2,"hydrogen_bond_donors":2,"canonical_smiles":"CC(=O)Nc1ccc(O)cc1","atc_level5":["N02BE01","N02BE51","N02BE71"],"standard_inchi_key":"RZVAJINKPMORJF-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Acetaminophen","parenteral":1,"availability_type":2,"polar_surface_area":49.33,"first_approval":1968,"aromatic_rings":1,"name":"Acetaminophen","max_phase":4,"therapeutic_flag":1,"oral":1,"usan":["Acetaminophen"]}}],"relationships":[{"id":"33802822","type":"NLP_SYNTACTICALLY_LINKED_WITH","startNode":"1682491","endNode":"246911","properties":{"pathlength":6,"source":"Pubmed","posneg":"Pos","uuid":"047bbeae-1c3c-11e6-8102-005056be6d3b","source_reference":["PMID:2739915"],"tool":"nlp_pipeline","source_version":"1463495465","predicate":"discharge","document_section":"sentence","confidence_score":1,"sentence_number":"S3","sentence_text":"When we studied <entity uuid=\"02bbd9fe-d110-11e5-94a7-005056be9332\" type=\"Chemical\">acetaminophen</entity> (paracetamol) metabolism, only 29.6% of <entity uuid=\"14abfed0-d185-11e5-b75f-005056be9332\" type=\"Condition\">PD</entity> patients excreted greater than 5% of the dose as the sulfate conjugate; the corresponding figure for controls was 83.9%.","category":"extracted","timestamp":1463495465}},{"id":"69968002","type":"INTERACTS_WITH","startNode":"246911","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Acetaminophen results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"6a66fa32-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:22230336"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234a302-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806313","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234a302-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349f06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806312","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349f06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349b00-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806311","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349b00-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234970e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806310","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234970e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349308-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806309","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2349308-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348f16-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806308","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348f16-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348b06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806307","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348b06-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348688-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806306","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2348688-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234826e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806305","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d234826e-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347e22-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"806304","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347e22-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347a30-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"806303","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347a30-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347634-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"488106","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":164.38,"topical":0,"inorganic_flag":-1,"alogp":3.29,"clinical_flag":0,"freebase_mwt":164.38,"source":"Stratified Medical Dictionary","uuid":"2ddfc4aa-d116-11e5-94a7-005056be9332","approved_flag":0,"unii":"I4JTX7Z7U2","source_version":"DICT_COMPOUND_160211","natural_product":-1,"rotable_bonds":1,"num_ro5_violations":0,"cas_rn":"76-06-2","chembl_id":"CHEMBL1327143","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/CCl3NO2/c2-1(3,4)5(6)7","full_molformula":"CCl3NO2","chirality":-1,"hydrogen_bond_donors":0,"canonical_smiles":"[O-][N+](=O)C(Cl)(Cl)Cl","standard_inchi_key":"LFHISGNCFUNFFM-UHFFFAOYSA-N","hydrogen_bond_acceptors":2,"pref_name":"Chloropicrin","parenteral":0,"availability_type":-1,"polar_surface_area":45.82,"aromatic_rings":0,"name":"Chloropicrin","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"806302","type":"IS_ASSOCIATED_WITH","startNode":"488106","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":5.97,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"d2347634-fd64-11e5-b260-005056be9332","source_reference":["OMIM:6"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967999","type":"INTERACTS_WITH","startNode":"488106","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"chloropicrin results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"701d7dc0-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:26352163"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce39ea-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441930","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce39ea-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce35d0-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441929","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce35d0-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce31b6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441928","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce31b6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2d9c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441927","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2d9c-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2900-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441926","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2900-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2450-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441925","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce2450-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1fc8-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441924","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1fc8-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1b9a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441923","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1b9a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1726-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441922","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1726-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1334-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441921","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce1334-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0f10-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"2441920","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0f10-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}},{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0b00-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441919","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0b00-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce070e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441918","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce070e-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0326-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441917","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40ce0326-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdff2a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441916","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdff2a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdfb1a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441915","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdfb1a-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdf674-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441914","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdf674-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdf1ec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441913","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdf1ec-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}},{"row":[[{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425},{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166},{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0},{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdede6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328},{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}]],"graph":{"nodes":[{"id":"1702459","labels":["All","Generic","Target"],"properties":{"source_version":"DICT_TARGET_160204","symbol":"TMEM230","name":"transmembrane protein 230","uniprot_search_strings":["Q5BJP5","Q8CIB6","Q96A57"],"source":"Stratified Medical Dictionary","human_pfam_hits":["PF05915"],"uuid":"ceb0a342-cbec-11e5-a271-005056be9332","timestamp":1456410425}},{"id":"1682491","labels":["All","Disease"],"properties":{"source_version":"DICT_DISEASE_160211","name":"Parkinson Disease","description":"A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions. [Disease Ontology]","orphan_disease":1,"source":"Stratified Medical Dictionary","uuid":"14abfed0-d185-11e5-b75f-005056be9332","timestamp":1457429345}},{"id":"894755","labels":["All","Molecule","Compound"],"properties":{"prodrug":-1,"full_mwt":172.94,"topical":0,"inorganic_flag":-1,"clinical_flag":0,"source":"Stratified Medical Dictionary","uuid":"752421e4-d111-11e5-94a7-005056be9332","approved_flag":0,"unii":"HIW548RQ3W","source_version":"DICT_COMPOUND_160211","natural_product":-1,"cas_rn":"10102-18-8","chembl_id":"CHEMBL112302","black_box_warning":0,"timestamp":1457446316,"standard_inchi":"InChI=1S/2Na.H2O3Se/c;;1-4(2)3/h;;(H2,1,2,3)/q2*+1;/p-2","full_molformula":"2Na.O3Se","chirality":-1,"canonical_smiles":"[Na+].[Na+].[O-][Se](=O)[O-]","standard_inchi_key":"BVTBRVFYZUCAKH-UHFFFAOYSA-L","pref_name":"Sodium Selenite","parenteral":0,"availability_type":-1,"name":"Sodium Selenite","max_phase":0,"therapeutic_flag":0,"oral":0}}],"relationships":[{"id":"69967997","type":"INTERACTS_WITH","startNode":"894755","endNode":"1702459","properties":{"source_version":"CTD_Jan_2016","remapped":1,"confidence_score":1,"description":"Sodium Selenite results in increased expression of TMEM230 mRNA","uniprot_id":"Q96A57","source":"CTD","category":"curated","uuid":"7aa011a4-dc98-11e5-9f8d-005056be9332","source_reference":["PMID:18175754"],"tax_id":9606,"tool":"structured_pipeline","timestamp":1456498166}},{"id":"2441912","type":"IS_ASSOCIATED_WITH","startNode":"894755","endNode":"1682491","properties":{"source_version":"CTD_Jan_2016","inference_score":11.23,"confidence_score":1,"source":"CTD","category":"inferred","uuid":"40cdede6-fd65-11e5-b260-005056be9332","source_reference":["OMIM:11"],"tool":"structured_pipeline","timestamp":1460104328}}]}}],"stats":{"contains_updates":false,"nodes_created":0,"nodes_deleted":0,"properties_set":0,"relationships_created":0,"relationship_deleted":0,"labels_added":0,"labels_removed":0,"indexes_added":0,"indexes_removed":0,"constraints_added":0,"constraints_removed":0}}